|
About the Executive
Officer
Mark E. Sobel, MD, PhD
Executive Officer
Dr. Mark Sobel received his B.A. from
Brandeis University in 1970, his M.D. from the Mount Sinai School of
Medicine in 1975 and his Ph.D. from the Graduate School of the City
University of New York in 1975 with a concentration in Biochemistry. He
completed a one-year residency in pediatrics at the Boston Children’s
Hospital Medical Center in 1976. He began a 25-year career at the
National Institutes of Health in 1976. From 1992-2001, Dr. Sobel was
Chief of the Molecular Pathology Section of the National Cancer
Institute. His main research interests were gene regulation, molecular
basis of metastasis, and molecular diagnostics. He was the Course Director
and main lecturer of the Concepts in Molecular Biology Course offered by
the American Society for Investigative Pathology from 1987 to 1999 and he
trained several of the current Molecular Diagnostics Laboratory Directors
in the United States. Dr. Sobel was awarded the United States Public
Health Service Commendation Medal in 1989, the Saul J. Howozitz, Jr.
Memorial Award from the Mount Sinai School of Medicine in 1991, and was
inducted into Alpha Omega Alpha in 1995. Dr. Sobel was President of the
American Society for Investigative Pathology from 1999-2000 and President
of the Association for Molecular Pathology in 1999.
Since 1996, Dr. Sobel has focused on
biomedical ethics and human subjects protections. He has been a major
spokesperson within the pathology and oncology communities to educate and
discuss appropriate means for clinicians and researchers to access human
biological materials to improve knowledge about human disease and
simultaneously respect human subjects. He is a consultant to the
Molecular Pathology Resource Committee of the College of American
Pathologists and is on the Board of Directors of AAHRPP (Association for
the Accreditation of Human Research Protection Programs). In 2001, Dr.
Sobel left the National Cancer Institute to become the Executive Officer
of the American Society for Investigative Pathology, the Association for
Molecular Pathology, the Association of Pathology Chairs, and several
affiliated societies involved in pathology and tissue resources.
|
 |
